2024年11月10日 · Diagnostics are the most important tools that empower the health workforce in the identification of diseases or health conditions. They allow the initiation of treatments in order to avoid further complications and costly treatments for patients.

2021年1月29日 · To address the lack of access to tests and testing services in multiple countries, WHO since 2018 has published a yearly essential diagnostics list (EDL), a basket of recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses. The latest edition, published today, …

2024年3月20日 · The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection, third edition” is the latest document replacing the one issued in 2021. This latest edition includes new recommendations on the use of a new class of diagnostic technologies: targeted next-generation sequencing (NGS) tests for the diagnosis of …

2024年6月27日 · In response, WHO established the Diagnostics Taskforce as a collaborative mechanism between all WHO programmes, at all three levels of the organization, to support the implementation of the resolution, and to serve as the entry point to all stakeholders working with countries on strengthening diagnostics capacity.Taskforce members support ...

2023年7月20日 · This document highlights the diagnostics available now to support scale-up and expanded access to screening to meet the growing testing demands in low- and middle-income countries (LMICs).

2020年2月10日 · In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. In vitro simply means ‘in glass’, meaning these tests are typically conducted in test tubes and similar equipment, as opposed to in vivo tests, which are conducted in the body itself.

2025年1月8日 · On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended treatments to prevent relapse of …

In general in 2022, levels of bacteriological confirmation were highest in high-income countries (median, 89%), where there is wide access to the most sensitive diagnostic tests, and lowest in low-income countries (median, 71%) (Fig. 2.2.3). Over-reliance on direct sputum smear microscopy is inherently associated with a relatively high proportion of pulmonary TB cases …

As part of ongoing efforts to enhance quality-assured testing options, the World Health Organization (WHO) has listed two additional mpox in vitro diagnostics under its Emergency Use Listing (EUL) procedure.

2024年8月29日 · WHO has asked manufacturers of mpox in vitro diagnostics (IVDs) to submit an expression of interest for Emergency Use Listing (EUL). WHO has been in ongoing discussions with manufacturers about the need for effective diagnostics, particularly in low-income settings. The request for EUL expressions of interest by manufacturers is the latest development in …